Indian Council of Medical Research has recently launched the Clinical Trials Registry-India to restore public confidence in clinical research
Indian Council of Medical Research (ICMR) has recently launched “the Clinical Trials Registry-India” (CTRI), where all clinical trials conducted in India would be registered. These trials are conducted to test efficacy of new drugs. The objective is to restore public confidence in clinical research.
The national registry will make the trails more transparent. It is the first such initiative in Asia. Any researcher who plans to conduct drug trials on humans is expected to declare the details of the exercise in the Registry that is jointly funded by the Department of Science and Technology, WHO and ICMR. The registry will require 20 items to be declared at the time of registration. These items meet the requirements of the World Health Organization International Clinical Trials Registry Platform.
Registration is voluntary, in some fields and mandatory to register and will serve as a primary register for the World Health Organization International Clinical Trials Registry Platform and register all trials in India.
India has also been included in WHO’s clinical trial registry platform. This is a major step for policymakers and scientists, who can now track local research activities, improve the quality of that research, and meet global standards for transparency. The general public also benefits by free access to a more complete picture of clinical research on diseases of interest in their own countries.